Rhonda Farnum, SVP, COMM & MEDICAL AFFAIRS at Theravance Biopharma, Inc. (TBPH), sold 9,360 shares at $10.29 ($97K) on 2023-11-21, disclosed to the SEC on 2023-11-22.
Scheduled sale ($97k) by SVP, COMM & MEDICAL AFFAIRS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.37 | 7,982 | $83K | 85.4% |
| 2 | $10.29 | 1,378 | $14K | 14.6% |
| Total | $10.36 avg | 9,360 | $97K | 100% |
| Filing → |
| TBPH | SELL | 2026-03-18 | $650K | — | Filing → |
| TBPH | SELL | 2025-12-05 | $1.2M | — | Filing → |
| TBPH | SELL | 2025-07-16 | $174K | — | Filing → |